DOSE-VOLUME HISTOGRAM PARAMETERS AND LATE SIDE EFFECTS IN MAGNETIC RESONANCE IMAGE-GUIDED ADAPTIVE CERVICAL CANCER BRACHYTHERAPY

被引:150
作者
Georg, Petra [1 ]
Lang, Stefan [1 ]
Dimopoulos, Johannes C. A. [1 ]
Doerr, Wolfgang [1 ,2 ]
Sturdza, Alina E. [1 ]
Berger, Daniel [1 ]
Georg, Dietmar [1 ]
Kirisits, Christian [1 ]
Poetter, Richard [1 ]
机构
[1] Med Univ Vienna, Dept Radiotherapy, A-1090 Vienna, Austria
[2] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Radiotherapy & Radiat Oncol, Dresden, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 02期
关键词
Cervical cancer; Image-guided brachytherapy; Dose-volume histogram; Organs at risk; Side effects; LATE RECTAL COMPLICATIONS; FRANCO-ITALIAN GLOSSARY; LENT-SOMA SCALES; UTERINE CERVIX; INTRACAVITARY BRACHYTHERAPY; ICRU REFERENCE; INTERSTITIAL BRACHYTHERAPY; DEFINITIVE RADIOTHERAPY; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY;
D O I
10.1016/j.ijrobp.2009.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the predictive value of dose volume histogram (DVH) parameters for late side effects of the rectum, sigmoid colon, and bladder in image-guided brachytherapy for cervix cancer patients. Methods and Materials: A total of 141 patients received external-beam radiotherapy and image-guided brachytherapy with or without chemotherapy. The DVH parameters for the most exposed 2, 1, and 0.1 cm(3) (D(2cc), D(1cc) and D(0.1cc)) of the rectum, sigmoid, and bladder, as well as International Commission on Radiation Units and Measurements point doses (D(ICRU)) were computed. Total doses were converted to equivalent doses in 2 Gy by applying the linear-quadratic model (alpha/beta = 3 Gy). Late side effects were prospectively assessed using the Late Effects in Normal Tissues Subjective, Objective, Management and Analytic score. The following patient groups were defined: Group 1: no side effects (Grade 0); Group 2: side effects (Grade 1-4); Group 3: minor side effects (Grade 0-1); and Group 4: major side effects (Grade 2-4). Results: The median follow-up was 51 months. The overall 5-year actuarial side effect rates were 12% for rectum, 3% for sigmoid, and 23% for bladder. The mean total D(2cc) were 65 +/- 12 Gy for rectum, 62 +/- 12 Gy for sigmoid, and 95 +/- 22 Gy for bladder. For rectum, statistically significant differences were observed between Groups 1 and 2 in all DVH parameters and D(ICRU). Between Groups 3 and 4, no difference was observed for D(0.1cc). For sigmoid, significant differences were observed for D(2cc) and D(1cc), but not for D(0.1cc) in all groups. For bladder, significant differences were observed for all DVH parameters only comparing Groups 3 and 4. No differences were observed for DICRU. Conclusions: The parameters D(2cc) and D(1cc) have a good predictive value for rectal toxicity. For sigmoid, no prediction could be postulated because of limited data. In bladder, DVH parameters were predictive only for major toxicity. (C) 2011 Elsevier Inc.
引用
收藏
页码:356 / 362
页数:7
相关论文
共 46 条
[1]  
[Anonymous], 1995, INT J RAD ONCOL BIOL, V31, P1048
[2]   MAXIMUM AND MEAN BLADDER DOSE DEFINED FROM ULTRASONOGRAPHY - COMPARISON WITH THE ICRU REFERENCE IN GYNECOLOGICAL BRACHYTHERAPY [J].
BARILLOT, I ;
HORIOT, JC ;
MAINGON, P ;
BONELEPINOY, MC ;
VAILLANT, D ;
FEUTRAY, S .
RADIOTHERAPY AND ONCOLOGY, 1994, 30 (03) :231-238
[3]   Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies [J].
Barillot, I ;
Horiot, JC ;
Maingon, P ;
Truc, G ;
Chaplain, G ;
Comte, J ;
Brenier, JP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :189-200
[4]   PHYSICS CONTRIBUTIONS AND CLINICAL OUTCOME WITH 3D-MRI-BASED PULSED-DOSE-RATE INTRACAVITARY BRACHYTHERAPY IN CERVICAL CANCER PATIENTS [J].
Chargari, Cyrus ;
Magne, Nicolas ;
Dumas, Isabelle ;
Messai, Taha ;
Vicenzi, Lisa ;
Gillion, Norman ;
Morice, Philippe ;
Haie-Meder, Christine .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01) :133-139
[5]   The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy [J].
Chen, SW ;
Liang, JA ;
Yang, SN ;
Liu, RT ;
Lin, FJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :955-961
[6]   The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix [J].
Clark, BG ;
Souhami, L ;
Roman, TN ;
Chappell, R ;
Evans, MDC ;
Fowler, JF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05) :989-993
[7]   Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary [J].
Davidson, SE ;
Burns, MP ;
Routledge, JA ;
Swindell, R ;
Bentzen, SM ;
West, CML .
RADIOTHERAPY AND ONCOLOGY, 2003, 69 (02) :195-200
[8]   Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma [J].
De Brabandere, Marisol ;
Mousa, Amr Gaber ;
Nulens, An ;
Swinnen, Ans ;
Van Limbergen, Erik .
RADIOTHERAPY AND ONCOLOGY, 2008, 88 (02) :217-226
[9]   Dosimetry of intracavitary applications in carcinoma of the cervix: Rectal dose analysis [J].
Deshpande, DD ;
Shrivastav, SK ;
Pradhan, AS ;
Viswanathan, PS ;
Dinshaw, KA .
RADIOTHERAPY AND ONCOLOGY, 1997, 42 (02) :163-166
[10]   Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk [J].
Dimopoulos, JCA ;
Schard, G ;
Berger, D ;
Lang, S ;
Goldner, G ;
Helbich, T ;
Pötter, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05) :1380-1388